FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors.
Clin Cancer Res
; 27(4): 928-932, 2021 02 15.
Article
in En
| MEDLINE
| ID: mdl-32967940
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzamides
/
Oncogene Proteins, Fusion
/
Drug Approval
/
Protein Kinase Inhibitors
/
Indazoles
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2021
Document type:
Article
Country of publication:
United States